News
Public · Published
GE HealthCare (GEHC) stock trades up, here is why
GE HealthCare reported third-quarter 2026 results that exceeded its expectations and raised full-year guidance. Revenue rose 7.2%, diluted earnings per share climbed 39.1% to $1.36, and free cash flow was $793 million.
Published:
Updated:
What happened
GE HealthCare reported third-quarter 2026 results that exceeded its expectations and raised full-year guidance. Revenue rose 7.2%, diluted earnings per share climbed 39.1% to $1.36, and free cash flow was $793 million.
Confirmed
Global impact / market context
A $23.7 billion backlog, which means ordered equipment not yet delivered and billed, points to steady future revenue. Rising profit per sale and strong cash available give the company more room to fund capital spending and return money to investors.
Analyst inference
The stock is not very volatile, with only 5 moves greater than 5% over the last year. A 7.2% jump therefore signals investors saw the results as meaningful, though the article says it may not change their view of the business.
Analyst inference
What to watch
- GE HealthCare raised its full-year outlook after third-quarter 2026 revenue rose 7.2% and organic revenue climbed 6.2%, so future reports will show whether that guidance is met. Confirmed
- Watch whether the $23.7 billion backlog converts into revenue on schedule, since delays in delivering ordered equipment would slow cash coming in and pressure capital spending plans. Proposed
- Track adjusted EBIT margin, which means profit from operations after certain adjustments, and free cash flow for signs that profit per sale and cash available can support growth. Analyst inference